Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Candidate drugs for non-alcoholic steatohepatitis (NASH)].
Terai S, Matsumoto T, Sakaida I. Terai S, et al. Among authors: matsumoto t. Nihon Yakurigaku Zasshi. 2007 Apr;129(4):271-5. doi: 10.1254/fpj.129.271. Nihon Yakurigaku Zasshi. 2007. PMID: 17435339 Review. Japanese. No abstract available.
Continuous high expression of XBP1 and GRP78 is important for the survival of bone marrow cells in CCl4-treated cirrhotic liver.
Marumoto Y, Terai S, Urata Y, Matsumoto T, Mizunaga Y, Yamamoto N, Jin H, Fujisawa K, Murata T, Shinoda K, Nishina H, Sakaida I. Marumoto Y, et al. Among authors: matsumoto t. Biochem Biophys Res Commun. 2008 Mar 14;367(3):546-52. doi: 10.1016/j.bbrc.2007.12.171. Epub 2008 Jan 7. Biochem Biophys Res Commun. 2008. PMID: 18182158
Medaka as a model for human nonalcoholic steatohepatitis.
Matsumoto T, Terai S, Oishi T, Kuwashiro S, Fujisawa K, Yamamoto N, Fujita Y, Hamamoto Y, Furutani-Seiki M, Nishina H, Sakaida I. Matsumoto T, et al. Dis Model Mech. 2010 Jul-Aug;3(7-8):431-40. doi: 10.1242/dmm.002311. Epub 2010 Apr 6. Dis Model Mech. 2010. PMID: 20371730 Free article.
Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy.
Terai S, Tanimoto H, Maeda M, Zaitsu J, Hisanaga T, Iwamoto T, Fujisawa K, Mizunaga Y, Matsumoto T, Urata Y, Marumoto Y, Hidaka I, Ishikawa T, Yokoyama Y, Aoyama K, Tsuchiya M, Takami T, Omori K, Yamamoto N, Segawa M, Uchida K, Yamasaki T, Okita K, Sakaida I. Terai S, et al. Among authors: matsumoto t. J Gastroenterol. 2012 May;47(5):491-7. doi: 10.1007/s00535-012-0580-5. Epub 2012 Apr 5. J Gastroenterol. 2012. PMID: 22488349 Review.
Serum transferrin as a predictor of prognosis for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma.
Zaitsu J, Yamasaki T, Saeki I, Harima Y, Iwamoto T, Harima Y, Matsumoto T, Urata Y, Hidaka I, Marumoto Y, Ishikawa T, Takami T, Yamamoto N, Kaino S, Uchida K, Terai S, Sakaida I. Zaitsu J, et al. Among authors: matsumoto t. Hepatol Res. 2014 May;44(5):481-90. doi: 10.1111/hepr.12141. Epub 2013 May 22. Hepatol Res. 2014. PMID: 23607437
10,225 results
You have reached the last available page of results. Please see the User Guide for more information.